Elzbieta M. van der Steen‐Banasik

Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts

Ellen Stelloo, Remi A. Nout, Elisabeth M. Osse et al. · Clinical Cancer Research · 2016 · 819 citations

Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer – A pooled analysis of PORTEC 1 and 2 trials

Tjalling Bosse, Elke E.M. Peters, Carien L. Creutzberg et al. · European Journal of Cancer · 2015 · 407 citations · Full text

A Pooled Analysis, Portec 1, Gynecological Surgery +8

Quality of Life After Pelvic Radiotherapy or Vaginal Brachytherapy for Endometrial Cancer: First Results of the Randomized PORTEC-2 Trial

Remi A. Nout, Hein Putter, Ina M. Jürgenliemk‐Schulz et al. · Journal of Clinical Oncology · 2009 · 269 citations

Quality Of Life, Surgical Oncology, Radiation Therapy +14

PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer

Anne Sophie V M van den Heerik, Nanda Horeweg, Remi A. Nout et al. · International Journal of Gynecological Cancer · 2020 · 235 citations · Full text

Short Androgen Suppression and Radiation Dose Escalation for Intermediate- and High-Risk Localized Prostate Cancer: Results of EORTC Trial 22991

M. Bolla, P. Maingon, C. Carrié et al. · Journal of Clinical Oncology · 2016 · 211 citations · Full text